west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "D-二聚体" 29 results
  • The Clinical Analysis of 25 Pulmonary Thrombus Embolism Cases

    摘要:目的: 分析肺动脉血栓栓塞症(PTE)的临床特征、诊断方法及治疗。提高诊断率和治愈率,改善预后。 方法 :回顾分析我院过去七年间收治的25例PTE患者的危险因素、临床表现、辅助检查、治疗情况等临床资料。 结果 :PTE的危险因素有深静脉血栓、高龄、心肺疾病、长期卧床等慢性基础疾病以及近期手术、外伤史等。其临床表现各异,D-二聚体、CT肺动脉造影(CTPA)敏感性高。 结论 :PTE临床表现多样,D-二聚体可作为筛选检查首选;CTPA可作为无创检查之首选。确诊后正确及时治疗可使预后显著改善。Abstract: Objective: to analyze the clinical character\ methods of diagnosis and therapies of pulmonary thrombus embolism, to improve the precisions of diagnosis and therapy, to make prognosis better. Method : 25 patients of pulmonary thrombus embolism admitted in our hospital in the past seven years, were analyzed by risk factors, clinical manifestation accessory examination and therapies. Result : risk factors of pulmonary thrombus embolism included thrombus in venue profound, senility the diseases of heart and lung, keeping in the bed for a long time, above clinic diseases, operation and trauma in the near future their clinical manifestations were different, the sensitivity of dipolymer and CT pulmonary arteriography were high. Conclusion : clinical manifestations of pulmonary thrombus embolism were various, dipolymer may be regarded as the firster to diagnbose pulmonary thrombus embolism, CT pulmonary arteriography may be regarded as the first non-traumatogenic examination to diagnose pulmonary thrombus emboklism. After the diagnosis, correct therapies in time can greatly improver prognosis.

    Release date:2016-09-08 10:12 Export PDF Favorites Scan
  • 华法林治疗慢性阻塞性肺疾病疗效观察

    目的探讨口服华法林抗凝治疗慢性阻塞性肺疾病(简称慢阻肺)的疗效。 方法采用病例对照研究。将40例存在中度以上阻塞性通气功能障碍的慢阻肺患者随机分为治疗组和对照组。对照组按指南常规治疗,治疗组在对照组基础上加用华法林抗凝治疗,疗程1年。观察比较治疗前后患者D-二聚体、呼吸困难指数、肺功能、急性加重病例数的变化情况。 结果两组患者D-二聚体定量均下降,治疗组下降值显著高于对照组下降值[(1.12±0.77)mg/L比(0.52±0.70)mg/L,t=2.614,P < 0.05],治疗组呼吸困难指数下降值显著高于对照组下降值[(1.85±0.49)分比(0.85±0.70)分,t=5.520,P < 0.05],治疗组肺功能(第1秒用力呼气容积占预计值百分比)增加值显著高于对照组增加值[(12.96±8.14)%比(1.76±2.72)%,t=5.839,P < 0.05],差异均有统计学意义。急性加重病例数治疗组6例,对照组10例。 结论长期口服小剂量华法林抗凝治疗能降低慢阻肺患者的D-二聚体水平,改善呼吸困难症状,改善肺功能,延缓肺功能下降,减少急性发作次数。

    Release date:2016-10-10 10:33 Export PDF Favorites Scan
  • D-二聚体水平测定在肺部疾病中的临床意义

    D-二聚体(D-dimmer)是血浆中交联纤维蛋白经纤溶酶水解所产生的一种特异性终末产物,当机体发生急性肺栓塞、肺癌、慢性阻塞性肺疾病、肺炎、急性呼吸窘迫综合征、慢性支气管炎、支气管哮喘等肺部疾病时会引发体内凝血机制的异常,血液呈高凝状态,继而引发纤溶系统亢进,观察患者的临床症状,积极检测D-二聚体水平的变化,对于疾病的诊断与治疗有着重要的参考价值 。现对近年来有关检测D-二聚体水平与肺部疾病关系的文献进行搜集整理,分析D-二聚体水平测定在肺部疾病的预防、诊断、治疗以及疗效的判断和预后方面的价值。

    Release date:2016-09-07 02:34 Export PDF Favorites Scan
  • The Value of Fibrinogen and D-dimer Detection in the Risk Stratification of Acute Pulmonary Embolism

    ObjectiveTo investigate the difference in fibrinogen and D-dimer (D-D) level among pulmonary embolism patients with different risk stratification. MethodsSixty pulmonary embolism patients admitted during January 2013 and January 2014 in our hospital were retrospectively analyzed.The general clinical data were gathered, and the patients were divided into a high-risk group (n=19), a moderate-risk group (n=21), and a low-risk group (n=20) according to the 2008 ESC Guidelines on the diagnosis and management of acute pulmonary embolism.Fourteen patients admitted simultaneously with dyspnea and chest pain without pulmonary embolism were randomly recruited as a control group.The plasma levels of fibrinogen and D-D were detected and compared between these groups. ResultsIn the pulmonary embolism patients, there were no significant statistical differences in general data between the patients with different risk degree.With the risk degree increased, the level of fibrinogen decreased and the level of D-D increased (P < 0.05).Compared with the pulmonary embolism patients, the level of fibrinogen was higher and the level of D-D was lower in the control group(P < 0.05).The level of fibrinogen was negatively correlated with the level of D-D with a correlation coefficient of-0.805. ConclusionsElevated fibrinogen is one of high risk factors of the pulmonary embolism. With the occurrence of pulmonary embolism, the level of fibrinogen becomes lower, suggesting the potential of fibrinogen as a indicator for pulmonary embolism diagnosis and risk stratification.

    Release date: Export PDF Favorites Scan
  • Application value of Caprini score and D-dimer in venous thromboembolism risk assessment following laparoscopic procedures

    ObjectiveTo summarize the clinical value of Caprini risk score (CRS) and D-dimer testing, both individually and in combination, for venous thromboembolism (VTE) risk stratification in patients undergoing laparoscopic surgery. MethodsThrough systematic literature review and analysis, we evaluated the advantages and limitations of these two tools in predicting VTE, with emphasis on their combined utility and respective detection characteristics. ResultsCRS demonstrated superior population stratification efficacy for initial VTE screening post-laparoscopy but showed limitations in assessing individual heterogeneity. D-dimer testing exhibited high sensitivity in detecting postoperative hypercoagulable states, yet its specificity was confounded by surgical stress-induced coagulation activation. Their integration established a multidimensional assessment system that significantly enhanced identification accuracy of high-risk VTE populations. ConclusionsThe combined application of CRS and D-dimer biomarkers optimizes postoperative VTE risk stratification management and provides evidence-based guidance for defining precise anticoagulation therapy timeframes. Future research should prioritize refinement of risk assessment tools to facilitate dynamic patient monitoring, thereby guiding targeted thromboprophylaxis and reducing occult VTE risk.

    Release date:2025-08-21 02:42 Export PDF Favorites Scan
  • Prediction of early in-hospital major adverse events by D-dimer level in patients with acute type A aortic dissection: A retrospective cohort study

    Objective To investigate the association between D-dimer levels within 2 hours of admission and in-hospital major adverse events (MAEs) in patients with acute type A aortic dissection (ATAAD) who underwent total arch replacement combined with frozen elephant trunk (FET) implantation. Methods This retrospective study included patients with ATAAD who underwent total arch replacement with FET implantation at Fuwai Yunnan Cardiovascular Hospital from September 2017 to December 2022. Patients were divided into two groups based on the occurrence of in-hospital MAEs: a MAEs group and a non-MAEs group (control). Perioperative data were compared between the two groups. Univariate and multivariate logistic regression analyses were performed to identify risk factors for in-hospital MAEs, which included in-hospital death, gastrointestinal bleeding, paraplegia, acute kidney injury, low cardiac output syndrome, stroke, respiratory failure, multiple organ dysfunction syndrome, and severe infection. The predictive value of D-dimer was evaluated using the area under the receiver operating characteristic curve (AUC). Results A total of 218 patients were included (157 males, 61 females), with a mean age of (51.54±9.79) years. There were 152 patients in the non-MAEs group and 66 in the MAEs group. The overall incidence of in-hospital MAEs was 30.3%, and the in-hospital mortality rate was 2.8% (6/218). Compared to the non-MAEs group, the MAEs group had significantly higher levels of D-dimer and lactate, as well as longer cardiopulmonary bypass time, aortic cross-clamp time, and ICU length of stay (all P<0.05). Multivariate logistic regression analysis identified D-dimer as an independent risk factor for in-hospital MAEs [OR=1.077, 95%CI (1.020, 1.137), P=0.013]. The AUC for the D-dimer level within 2 hours of admission to predict in-hospital MAEs was 0.83 [95%CI (0.736, 0.870), P<0.001]. The optimal cutoff value was 2.2 μg/mL, with a sensitivity of 84.8% and a specificity of 73.0%. Conclusion The serum D-dimer level is an independent risk factor for in-hospital MAEs in patients with ATAAD following total arch replacement with FET implantation. D-dimer levels on admission can help clinicians optimize risk stratification and perioperative management, potentially reducing the incidence of early adverse events.

    Release date:2025-10-27 04:22 Export PDF Favorites Scan
  • Establishment of the Model of Local Mesenteric Venous Thrombosis in Rabbits

    【摘要】 目的 探讨建立局部性家兔肠系膜静脉血栓(MVT)模型的方法。 方法 于2008年1月,将36只家兔随机均分为3组,肠系膜前静脉局部阻断加静脉分支注射凝血酶,A组80 U/mL,B组40 U/mL,C组注射生理盐水1 mL。观测血栓形成时间、范围和周围静脉血D-二聚体(DD)变化。 结果 A、B两组均可建立控制范围内稳定MVT模型,血栓形成时间分别为(15.6±2.0) min和(22.3±2.5)min,两组比较有统计学意义(Plt;0.001);术前A、B两组DD为(68.4±5.7)ng/mL、(72.7±6.4)ng/mL,血栓形成后为(209.0±24.0)ng/mL、(215.4±17.6)ng/mL,组内比较有统计学意义(Plt;0.001);C组不形成血栓。 结论 局部静脉阻断加凝血酶注射法可建立稳定和范围可控的MVT模型,建模前后血浆DD值有一定实验参考价值。【Abstract】 Objective To establish the model of local mesenteric venous thrombosis (MVT) in rabbits. Methods In January 2008, 36 rabbits were randomly divided into three groups with 12 rabbits in each. The anterior mesenteric veins were blocked regionally, and at the same time the rabbits were injected with thrombin 80 U/mL through the branches of mesenteric vein in group A, 40 U/mL in group B, and 1 mL normal saline in group C. Time and range of thrombosis were observed, and D-dimer level in peripheral vein was tested. Results Stable MVT model was established in intended region in both group A and B. There was a significant reduction of thrombosis time in group A [(15.6±2.0) minutes] when compared with that in group B [(22.3±2.5) minutes] (Plt;0.001). The levels of D-dimer in group A two hours after operation [(209.0±24.0) ng/mL] increased significantly compared with that before the operation [(68.4±5.7) ng/mL](Plt;0.001); while the same condition was found in group B [(215.4±17.6) ng/mL vs (72.7±6.4) ng/mL] (Plt;0.001). No thrombus was found in group C. Conclusion Stable MVT model with controllable thrombotic range can be established by regional vein blockade plus thrombin injection. Plasma D-dimer levels before and after model establishment could be as a parameter for assessing the experiment.

    Release date:2016-09-08 09:51 Export PDF Favorites Scan
  • Evaluation of Quality of Chinese Literature on D-dimer Diagnostic Methodology

    Objective To evaluate the quality of Chinese literatures on the methodology of D-dimer diagnostic test. Method We searched CNKI (1994 to 2006) and CBM (1978 to 2006) for articles involving the diagnostic tests of D-dimer for coagulation disorders. Result A total of 63 relevant articles were retrieved and 7 were included in our review. Only one of these provided useful data on two two table for the evaluation of diagnostic accuracy. Conclusions Few studies on the diagnostic tests of D-dimer have been performed and publ ished in China, all of poor quality. Further studies should focus on clinical diagnostic sensitivity and specificity, so as to provide more valuable information for readers.

    Release date:2016-09-07 02:16 Export PDF Favorites Scan
  • 内源性硫化氢在肺栓塞患者中的表达及临床意义

    目的 探讨硫化氢( H2S) 在肺栓塞发病过程中的作用及与D-二聚体的关系。方法 在肺栓塞患者治疗前后应用ELISA 法检测外周血D-二聚体, 敏感硫电极方法检测血浆H2 S 水平。结果 肺栓塞患者抗凝治疗前血浆中H2S 水平高于正常对照组和抗凝治疗后( P lt;0. 05) 。抗凝治疗前血清中D-聚体含量明显增高, 与抗凝治疗前H2S 的变化呈正相关( r =0. 022) 。结论 内源性H2 S参与了肺栓塞的发生和发展, 与D-二聚体呈正相关。

    Release date:2016-09-13 04:07 Export PDF Favorites Scan
  • Predictive value of serum procalcitonin, D-dimer and decoy receptor 3 for prognosis of patients with AECOPD and respiratory failure undergoing non-invasive ventilation

    Objective To explore the predictive value of serum procalcitonin (PCT), D-dimer (D-D) and decoy receptor 3 (DcR3) for prognosis of patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and respiratory failure undergoing non-invasive ventilation (NIV). Methods A total of 95 patients with AECOPD and respiratory failure undergoing basic treatment and NIV in the hospital were retrospectively enrolled between September (n=65) 2017 and February 2021. According to prognosis after treatment, they were divided into a good prognosis group and a poor prognosis group (n=30). The general data of all patients were collected. The influencing factors of prognosis were analyzed by multivariate logistic regression model. The levels of DcR3, PCT and D-D were detected by enzyme-linked immunosorbent assay, colloidal gold colorimetry and immunoturbidimetry. The patients condition was assessed by scores of acute physiology chronic health evaluation scoring system Ⅱ (APACHEⅡ). The partial pressure of arterial oxygen (PaO2) and partial pressure of carbon dioxide (PaCO2) were recorded. And the above indexes between the two groups were compared. The relationship between DcR3, PCT, D-D and APACHEⅡ score, PaO2, PaCO2 was analyzed by Pearson correlation analysis. The prognostic value of DcR3, PCT and D-D was analyzed by receiver operating characteristic (ROC) curve. Results There was no significant difference in gender, GOLD grading or underlying diseases between the poor prognosis group and the good prognosis group (P>0.05), but there were significant differences in age, DcR3, PCT, D-D, APACHEⅡ score, PaO2 and PaCO2 after treatment (P<0.05). DcR3, PCT, D-D, APACHEⅡ score and PaCO2 in the poor prognosis group were higher than those in the good prognosis group, while PaO2 was lower than that in the good prognosis group (P<0.05). Logistic regression analysis showed that DcR3 ≥5.50 ng/mL (OR=21.889), PCT ≥ 5.00 μg/L (OR=3.782), D-D ≥3.00 μg/L (OR=4.162) and APACHEⅡ score ≥20 points (OR=2.540) were all influencing factors of prognosis (P<0.05). The results of Pearson correlation analysis showed that DcR3, PCT and D-D were positively correlated with APACHEⅡ score and PaCO2, while negatively correlated with PaO2 (P<0.05). The results of ROC curve analysis showed that area under ROC curve of DcR3, PCT and D-D for predicting the prognosis were 0.745 (95%CI 0.631 - 0.859), 0.691 (95%CI 0.579 - 0.803) and 0.796 (95%CI 0.696 - 0.895), respectively (P<0.05). Conclusion The serum DcR3, PCT and D-D levels are related to disease progression in patients with AECOPD and respiratory failure after NIV, which have good predictive efficiency for prognosis and can be applied as important biological indexes to evaluate prognosis and guide treatment.

    Release date:2023-09-02 08:56 Export PDF Favorites Scan
3 pages Previous 1 2 3 Next

Format

Content